CAJ | 학술논문

消化道恶性肿瘤术后复发率较高,传统静脉化疗、肠腔内灌注化疗等效果不佳,且不良反应大.近年来国内外学者开始对腹腔化疗进行研究,并取得了一些进展,但对术后早期腹腔化疗是否影响吻合口愈合等问题,仍存在争议.对于腹腔化疗药联合哪些药物可使化疗效果更佳,仍无统一的标准.本研究对目前腹腔化疗的有关问题特别是腹腔化疗的有效性及安全性等进行综述.
소화도악성종류술후복발솔교고,전통정맥화료、장강내관주화료등효과불가,차불량반응대.근년래국내외학자개시대복강화료진행연구,병취득료일사진전,단대술후조기복강화료시부영향문합구유합등문제,잉존재쟁의.대우복강화료약연합나사약물가사화료효과경가,잉무통일적표준.본연구대목전복강화료적유관문제특별시복강화료적유효성급안전성등진행종술.
The postoperative recurrence rate of gastrointestinal cancer is high. The therapeutic effect of traditional chemotherapy is not satisfactory, such as chemotherapy through vein and intestine perfusion and so on, and the side effects are obvious. In recent years, researchers in and abroad have begun to study the effect of intraperitoneal chemotherapy. Whether early postoperative intraperitoneal chemotherapy affect the healing of anastomotic stoma is still controversial. Intraperitoneal chemotherapy combined with medicine can achieve a better therapeutic effect. This article reviewed current issues of intraperitoneal chemotherapy, espe-cially its validity and safety.